Acute Intermittent Porphyria Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Acute Intermittent Porphyria Market is expected to growing at a CAGR of 5% during the forecast period of 2022-2028.

Acute intermittent porphyria (AIP) is an inherited metabolic disorder. It affects the production of heme, which is a prosthesis of hemoglobin that binds to oxygen. It is caused by low levels of porphobilinogen deaminase. The main causes of acute intermittent porphyria are insomnia, anorexia and urine color, myalgia and urinary retention. Acute intermittent porphyria can lead to the formation of liver tumors (hepatocellular carcinoma) and kidney failure. Problems related to gastrointestinal, urinary tract problems, psychological problems, and neurological problems are the symptoms of this disease. Porphyria is caused by the development of chemicals in the body, which produce a substance called porphyrin. Panhematin, givlaari, chlrpromazine, and hemin are some medications, which can be used for the treatment of this disease.

Market Segments

By Diagnosis

• Urine Test
• Blood test
• Serum test
• DNA test
• Others

By Treatment

• Prophylactic Hematin Infusions
• Gonadotropin-Releasing Hormone Analogues
• Others

Key Players

• Siemens AG
• Boston Scientific Corporation
• Danaher
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• ARKRAY, Inc.
• ACON Laboratories, Inc.
• Sonova Holding AG
• C. R. Bard, Inc.
• Sysmex Corporation
• Nurotron Biotechnology Co. Ltd.

Scope of the Report

The research study analyzes the global Acute Intermittent Porphyria industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Acute Intermittent Porphyria Market Report

1. What was the Acute Intermittent Porphyria Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Acute Intermittent Porphyria Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Acute Intermittent Porphyria Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.